|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2970473 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717294.4 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-16 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (86) | Number | PCT/US2014/024208 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/159562 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361783184 P | 2013-03-14 | US |
| (72) |
BARNHART, Bryan, US
JURE-KUNKEL, Maria, N., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | DR5 agonisto ir anti-PD-1 antagonisto derinys ir naudojimo būdai |
| COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2019-02-21 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-03-12 |